BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7151640)

  • 1. Pharmacokinetics of digoxin in low-birth-weight infants.
    Collins-Nakai RL; Schiff D; Ng PK
    Dev Pharmacol Ther; 1982; 5(1-2):86-97. PubMed ID: 7151640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose kinetics of digoxin in neonates.
    Collins-Nakai RL; Schiff D; Ng PK
    Pediatr Pharmacol (New York); 1985; 5(2):117-22. PubMed ID: 4047750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and echocardiographic effects of digoxin in low birth weight infants with left-to-right shunting due to patent ductus arteriosus.
    Warburton D; Bell EF; Oh W
    Dev Pharmacol Ther; 1980; 1(2-3):189-200. PubMed ID: 6927548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin pharmacokinetics in premature infants.
    Hastreiter AR; Simonton RL; van der Horst RL; Benawra R; Mangurten H; Lam G; Chiou WL
    Pediatr Pharmacol (New York); 1982; 2(1):23-31. PubMed ID: 7110753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of digoxin in sheep: limitations of the use of biological half-life for interspecies extrapolation.
    Dix LP; Bai SA; Rogers RA; Anderson DL; Riviere JE
    Am J Vet Res; 1985 Feb; 46(2):470-2. PubMed ID: 3994115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 24-hour serum digoxin level as a prognosticator of dosage requirement in low-birth-weight (LBW) infants.
    Ng PK; Collins-Nakai RL
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):71-9. PubMed ID: 6648043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of ceftazidime in newborn infants].
    Rule R; Martiarena NJ; Rubio M; Magadan A
    Medicina (B Aires); 1993; 53(3):207-10. PubMed ID: 8114628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal clearance of digoxin in premature neonates.
    Ng PK; Cote J; Schiff D; Collins-Nakai RL
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):207-16. PubMed ID: 7335951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum digoxin levels in neonates whose weights are less than 1,500 grams.
    Patterson MW; Reid G; Sandor GG
    Pediatr Pharmacol (New York); 1982; 2(3):217-21. PubMed ID: 7162876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM; Blakley RL; Santana VM; Crom WR
    Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; BelyÄ­ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants.
    Allegaert K; Debeer A; Cossey V; Rayyan M; Devlieger H
    Pediatr Crit Care Med; 2006 Mar; 7(2):143-6. PubMed ID: 16446602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin pharmacokinetics in very low birth weight neonates.
    Leonard MB; Koren G; Stevenson DK; Prober CG
    Pediatr Infect Dis J; 1989 May; 8(5):282-6. PubMed ID: 2657617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.
    van den Anker JN; Hop WC; Schoemaker RC; van der Heijden BJ; Neijens HJ; de Groot R
    Br J Clin Pharmacol; 1995 Nov; 40(5):439-43. PubMed ID: 8703647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
    Bonelli J; Haydl H; Hruby K; Kaik G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependant factors influencing digoxin pharmacokinetics in the postnatal puppy.
    Singh S; Gadgil S; Mirkin BL
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):87-101. PubMed ID: 684281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and elimination of digoxin in infants.
    Wettrell G
    Eur J Clin Pharmacol; 1977; 11(5):329-35. PubMed ID: 880972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.